Abstract
We show that the acceleration index, a novel yet simple indicator that measures acceleration of viral spread (Baunez et al., 2021), corrects the reproduction number for the time-varying amount of tests. Not doing so results in the reproduction number being a biased estimate of viral acceleration and we provide a formal decomposition of the resulting bias. When applied to French data for the COVID-19 pandemic (from May 13 to November 19, 2020), our decomposition shows that the reproduction number consistently underestimates the resurgence of the pandemic since the summer of 2020, compared to the acceleration index which accounts for the time-varying volume of tests. Because the acceleration index aggregates all the relevant information and captures in real time the sizable time variation featured by viral circulation, it is a sufficient statistic to track the pandemic’s propagation. As such it is a more accurate indicator to track the dynamics of an infectious disease outbreak in real time.
JEL Classification Numbers I18; H12
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* The authors thank the Editor and three referees for suggestions that prompted us to improve the paper. This work was supported by the French National Research Agency Grant ANR-17-EURE-0020, and by the Excellence Initiative of Aix-Marseille University - A*MIDEX.
Email:christelle.baunez{at}univ-amu.fr
Email:mickael.degoulet{at}univ-amu.fr
Email:stephane.luchini{at}univ-amu.fr
Email:matteo.pintus{at}agroparistech.fr
Email:patrick.pintus{at}univ-amu.fr
Email:miriam.teschl{at}ehess.fr
This is a thoroughly revised version after the feedback from 3 referees, with new material.
Data Availability
Data used publicly available.
